Tag: Dupixent

EoE Science Minutes: Dupixent as a potential effective treatment of EoE

EoE Science Minutes: Dupixent as a potential effective treatment of EoE

Dupixent is a monoclonal antibody (dupilumab) blocking type 2 inflammation, specifically inhibiting interleukin 4 and interleukin 13. Dupixent is currently approved for use in several type 2 chronic inflammatory diseases such as moderate-to-severe atopic dermatitis, asthma, and nasal polyps. It is well known that EoE